Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context by Thomas Gaziano, José María Castellano, Amy Dymond, Alissa Looby, Stuart Mealing, Ruth Owen, Stuart Pocock, José Ramón González-Juanatey, Alberto Cordero, Antonio Fernández-Ortiz, Aleš Linhart, François Schiele, Wolfram Doehner, Luisa Ojeda Fernández, Valentín Fuster

Get full text

Association of Race With Risk of Incident Cardiovascular Disease, Coronary Heart Disease, Heart Failure, and Stroke by Michael J. Domanski, MD, Colin O. Wu, PhD, Xin Tian, PhD, Haiou Li, PhD, Ruba Shalhoub, MS, Rui Miao, PhD, Ahmed A. Hasan, MD, PhD, Yi Huang, PhD, Jared P. Reis, PhD, Jerome L. Fleg, MD, Jamal S. Rana, MD, Kai Zhang, PhD, Albert Hicks, MD, Norrina B. Allen, PhD, Hongyan Ning, PhD, Sejong Bae, PhD, David R. Jacobs, Jr., PhD, Donald M. Lloyd-Jones, MD, ScM, Valentin Fuster, MD, PhD

Get full text